Neuroimmunology News and Research

RSS
Drug reduces risk of relapse with neuromyelitis optica spectrum disorder, study shows

Drug reduces risk of relapse with neuromyelitis optica spectrum disorder, study shows

Study of MS patients shows 18% were given wrong diagnoses

Study of MS patients shows 18% were given wrong diagnoses

Inauguration of NIDD, the Neuroimmunology Drug Development Summit

Inauguration of NIDD, the Neuroimmunology Drug Development Summit

Tactile and proprioceptive stimulation improves effects of perinatal brain injuries in mice

Tactile and proprioceptive stimulation improves effects of perinatal brain injuries in mice

Research reveals how metabolites can be used to inhibit epigenetic mechanisms and treat MS

Research reveals how metabolites can be used to inhibit epigenetic mechanisms and treat MS

Researchers explain why T cells lose their protective ability in inflamed tissues

Researchers explain why T cells lose their protective ability in inflamed tissues

Researcher identifies putative mechanism that leads to degeneration of axons in multiple sclerosis

Researcher identifies putative mechanism that leads to degeneration of axons in multiple sclerosis

New editorial proposes changes to improve minority representation in clinical trials

New editorial proposes changes to improve minority representation in clinical trials

Answering the Biggest Neurological Research Questions of Today

Answering the Biggest Neurological Research Questions of Today

Researchers create new approach to classify patients with Alzheimer's disease

Researchers create new approach to classify patients with Alzheimer's disease

B cell accumulation triggers nervous system damage in MS

B cell accumulation triggers nervous system damage in MS

3 Harvard scientists receive Allen awards for work in neuroimmunology, developmental biology, cancer

3 Harvard scientists receive Allen awards for work in neuroimmunology, developmental biology, cancer

Ten Allen Distinguished Investigators for 2018 announced by Paul G. Allen Frontiers Group

Ten Allen Distinguished Investigators for 2018 announced by Paul G. Allen Frontiers Group

Biogen and Eisai present detailed results from phase 1b study of aducanumab at CTAD meeting

Biogen and Eisai present detailed results from phase 1b study of aducanumab at CTAD meeting

Axol's Human iPSC-derived Microglia for neuroimmunology research

Axol's Human iPSC-derived Microglia for neuroimmunology research

Genervon reports new findings that drug candidate GM6 attenuates Alzheimer's disease in mice model

Genervon reports new findings that drug candidate GM6 attenuates Alzheimer's disease in mice model

Biogen and Eisai announce results of LTE Phase 1b study of aducanumab for treating MCI

Biogen and Eisai announce results of LTE Phase 1b study of aducanumab for treating MCI

CMSC's educational conference provides up-to-date information on multiple sclerosis

CMSC's educational conference provides up-to-date information on multiple sclerosis

Blood test could provide low-cost alternative to MRI for monitoring disease activity in MS

Blood test could provide low-cost alternative to MRI for monitoring disease activity in MS

Mayo Clinic launches new clinical test that distinguishes IDDs from multiple sclerosis

Mayo Clinic launches new clinical test that distinguishes IDDs from multiple sclerosis